The human sexual response and the sexual dysfunctions
- Disorder
How sexual desire, arousal, orgasm and resolution work, and the lasting problems with them that cause distress, often from medical causes or drugs.
What it is
The classic linear model describes the sexual response as spontaneous desire, then excitement and plateau, orgasm and resolution; the circular model of Rosemary Basson and colleagues adds that sexual activity often starts from emotional intimacy or other motives, and desire can be responsive, building once arousal begins. DSM-5-TR requires symptoms on at least 75 percent of occasions for at least 6 months, causing distress. Sexual problems are common: an estimated 30 to 50 in 100 women report them, but only about 12 in 100 are distressed, and distress is what makes a problem a disorder.
Key facts
- Erection is mediated by a sacral parasympathetic reflex; emission begins with stimulation of alpha-adrenergic receptors.
- Premature ejaculation is usually caused by inexperience, anxiety and other psychological factors; SSRIs can contribute to delayed ejaculation.
- Female sexual interest/arousal disorder merged the former separate desire and arousal disorders.
- Genito-pelvic pain/penetration disorder combines pain with intercourse, fear of pain and pelvic floor muscle tightening; low estrogen with vaginal dryness can contribute.
- Depression, anxiety, past sexual trauma and conflict in the relationship all inhibit desire and arousal.
Step by step
- Take a detailed sexual history, in private, including the relationship, mental health and any past trauma.
- Review every drug: SSRIs, antipsychotics, some antihypertensives, 5-alpha-reductase inhibitors and antiandrogens.
- Examine the patient and order tests such as testosterone, prolactin and thyroid function when the history suggests them.
- Treat the causes and offer psychological treatment such as cognitive behavioral therapy or mindfulness-based practices, with or without medicines.
- Refer for pelvic floor therapy when pain or musculoskeletal problems predominate.
The DSM-5-TR sexual dysfunctions at a glance
| Dysfunction | Core feature | Common contributors | First approach |
|---|---|---|---|
| Male hypoactive sexual desire disorder | Persistently low or absent sexual thoughts and desire | Depression, drugs, relationship problems | Treat causes; couple or sex therapy |
| Low desire from low testosterone | Low desire with a low morning testosterone level | Hypogonadism | Measure morning testosterone |
| Erectile disorder | Cannot get or keep an erection firm enough | Diabetes, neurological disease, drugs, anxiety | See the erectile dysfunction page |
| Premature (early) ejaculation | Ejaculation earlier than wished | Inexperience, anxiety | Stop-start and squeeze techniques |
| Delayed ejaculation | Marked delay or absence of ejaculation | SSRIs, psychological factors | Review drugs; psychological treatment |
| Female sexual interest/arousal disorder | Little interest or desire and/or low arousal | Depression, drugs, relationship conflict | Cognitive behavioral therapy or mindfulness; flibanserin or bremelanotide in premenopausal women |
| Female orgasmic disorder | Orgasm delayed, rare, absent or much less intense | Anxiety, SSRIs | Psychological treatment; review drugs |
| Genito-pelvic pain/penetration disorder | Pain, fear of pain, pelvic floor tightening with penetration | Low estrogen with vaginal dryness, past trauma | Pelvic floor therapy, treat dryness |
| Substance/medication-induced dysfunction | Onset with starting or raising a drug | SSRIs, antipsychotics, some antihypertensives | Lower the dose or switch to a drug with fewer effects |
| Paraphilic disorders (not a dysfunction) | Atypical sexual interests causing distress or harm | Different category | See the paraphilic disorders page |
Clinical notes
- Take a sexual history routinely, in private and without assumptions about orientation or relationships; review every drug.
- Look for and treat medical causes, and check testosterone, prolactin and thyroid function when the history suggests them.
- Cognitive behavioral therapy and mindfulness-based practices are effective, with or without medicines.
- For SSRI-related problems, options include lowering the dose or switching to an antidepressant that impairs sexual response less, such as bupropion or mirtazapine; data on adding bupropion conflict.
- Flibanserin and bremelanotide are approved for low desire in premenopausal women; testosterone is not recommended in premenopausal women.
Test yourself
Think of the answer, then tap the question to see it.
What is the key idea of Basson's circular model of sexual response?
Desire can be responsive: sexual activity may start from intimacy or other motives, and desire can build after arousal begins.
Which antidepressant class commonly causes sexual dysfunction, and what does it cause?
SSRIs: in more than half of patients, mainly trouble reaching orgasm, plus lower libido and erectile dysfunction.
Which antidepressants have the fewest sexual side effects?
Bupropion and mirtazapine, which lack the sexual adverse effects of SSRIs.
What makes a sexual problem a DSM-5-TR sexual dysfunction?
Symptoms on at least 75 percent of occasions for at least 6 months that cause distress.
What mediates erection, and what starts emission?
Erection: a sacral parasympathetic reflex; emission: stimulation of alpha-adrenergic receptors.
Elsewhere in DurgiPedia
- Erection and ejaculation
- Menopause
- Testosterone and its actions
- Prolactin and its control by dopamine
- Sexuality and sexual health in nursing care
Connections
Educational content on behavior and the clinical relationship; not a diagnostic or treatment guide and no substitute for assessment by a health professional. If you or someone near you is at risk, seek help now from an emergency service or a mental-health helpline.
Sources: Overview of Female Sexual Function and Dysfunction (MSD Manual Professional Edition, 2026); Overview of Male Sexual Function and Dysfunction (MSD Manual Professional Edition, 2026); Sexual Interest/Arousal Disorder (MSD Manual Professional Edition, 2026); Drug Treatment of Depression (MSD Manual Professional Edition, 2026).
Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake
Representative model, for educational purposes only.
